American Heart Association Scientific Sessions OnDemand 2024

1. Overview

The American Heart Association Scientific Sessions OnDemand 2024 offers premier cardiovascular education, highlighting the latest scientific discoveries, late-breaking clinical trial updates, and advanced therapies. This program covers a comprehensive range of topics from interventional cardiology and heart failure to preventive science and digital health innovations.
Course Date: 2024
2. Learning Objectives

Evaluate late-breaking clinical trials and their direct implications for modern cardiovascular care.

Implement updated AHA guidelines for treating heart failure, arrhythmias, and ischemic heart disease.

Analyze the integration of artificial intelligence and digital health in cardiovascular diagnosis and management.

Discuss emerging pharmacological therapies and novel interventional strategies for structural heart diseases.

Assess health equity initiatives and community-based approaches to reducing global cardiovascular disparities.

3. Target Audience

Best for cardiologists and cardiovascular researchers who want updates on late-breaking clinical trials, AHA guidelines, and digital health.

4. Topics

100 Years of the American Heart Association_ Where We Have Come, Where We Are, and Where We are Going in Pediatric and Congenital Heart Care[cite: 1].

3CPR Mid-Career Achievement Award and Lecture[cite: 1, 2].

7 Questions about CVD in Women and Underrepresented Populations[cite: 2].

A Decade in the Making_ New Guidelines on Perioperative CV Management[cite: 2].

ACS Beyond Plaque Rupture_ Meet the Experts[cite: 2, 3].

Addressing Family-centered Care Across the Lifespan_ A Spicy Debate of Peds and Adult Experts[cite: 3].

Addressing Health Equity Through Cohorts_ Reaching Every Nook and Cranny[cite: 3, 4].

Advanced Heart Failure Feud_ DCD, Recovery, and Xenotransplantation![cite: 4].

Advanced Methodologies to Decipher Heart Failure Pathophysiology[cite: 4].

Afib and the Heart Brain Axis From Patient to Population, From Innovation to Implementation[cite: 4, 5].

AHA 100 Years on the Global Health Stage[cite: 5].

AHA Early Career Investigator Showcase_ Spotlight on AHA Funded Research_ Basic Science[cite: 5].

AHA-funded Research_ Helping Me Find My Research Path[cite: 5, 6].

AI in Publishing Debate_ Hype vs. Hope[cite: 6].

AI-enabled Digital Biomarkers for Enhancing Cardiovascular Disease Prediction and Management_ A JAMA Session[cite: 6].

An Historical Understanding of Acute Coronary Syndromes_ Lessons from Great Debates of the Last Century[cite: 6, 7].

An Introduction to Clinical Cardiovascular Genetic Testing Best Practices_ A Flipped Classroom-Style Session (GPM)[cite: 7].

Ancel Keys Memorial Lecture[cite: 7].

Annual Lipid Updates – 2024[cite: 7, 8].

Applications of AI and Digital Technology in Heart Failure Management[cite: 8].

Applying Advances in Risk Prediction to PREVENT CV Disease[cite: 8].

Approaching the Fork in the Road_ Strategies and Outcomes for Managing Bifurcation Lesions[cite: 8, 9].

At the Heart of the Problem_ Harnessing Implementation Science to DECIPHER Evidence Into Community Action[cite: 9].

Atherosclerosis_ Time for Resolution and a Look Beyond Anti-inflammation[cite: 9, 10].

Atrial Fibrillation and Stroke_ From Wearables and Implantables to Prevention and Outcomes – CRYSTAL Clear or Clear as Mud_[cite: 10].

Beneath the Surface_ Subclinical Cardiovascular Disease and Prevention[cite: 10, 11].

Best of the Best_ Top Scoring Abstracts From Cardiovascular Surgery and Anesthesia[cite: 11].

Beyond Stethoscopes AIs Impact on Cardiovascular Screening[cite: 11].

Blood Fuels the Heart_ The Discovery, Development and Future of Anti-platelet Therapy in Cardiovascular Diseases[cite: 11, 12].

Brain Vasculitis and Cardiovascular Health[cite: 12].

Breaking Through the Norwood Ceiling_ Reimagining Care to Improve Outcomes for Babies Born With Hypoplastic Left Heart Syndrome[cite: 12, 13].

Bridging the Gaps in the Management of Cardiac Amyloidosis – Where are we in 2024[cite: 13].

Bringing AI to Clinical Decision Making in Vascular Medicine AI in 2024[cite: 13, 14].

Bringing Surveillance Data Back to the Community Data Resources and Modernization[cite: 14].

Building a Transatlantic Collaborative Network in Critical Care Cardiology Education and Care Delivery Collective Wisdom from AHA[cite: 14, 15].

Building Community_ Improving Equity Through Dissemination, Implementation, and Community Engagement Science[cite: 15].

Building on the 4 Pillars_ Novel Trials of Medical Therapy for Heart Failure[cite: 15, 16].

Can Intensive BP Control Protect Against Cardiovascular Disease and Mortality_[cite: 16].

Cardiac and Systemic Metabolic Pathway(s) to Heart Failure[cite: 16].

Cardiac Evaluation in the Athlete_ When Should I Worry_[cite: 16, 17].

Cardiac Fibrosis Mechanisms and Repair[cite: 17].

Cardiac Physiological Pacing_ Riding the Cardiac Conduction SuperHighway in HFrEF – New Guidelines and Clinical Outcomes[cite: 17].

Cardio-Obstetrics_ Is a Dedicated Subspecialty Ready for Prime Time_[cite: 17, 18].

Cardio-Oncology in the Real World_ Disparities and Health Inequity in Cardiovascular and Cancer Outcomes[cite: 18].

Cardiogenic Shock_ A Team-Based Approach to Discovery and Clinical Management[cite: 18, 19].

Cardiometabolic Factors_ Global Burden and Innovative Solutions[cite: 19].

Cardiovascular Disease in Women – Where Are We and Where Do We Need to Go[cite: 19].

Cardiovascular Health Challenges of the Latin Community in North America (AHA Joint Session with Interamerican Society of Cardiology)[cite: 19, 20].

Cardiovascular-Kidney-Metabolic (CKM) Healthcare Models_ Global Perspectives on Achieving Interdisciplinary Care[cite: 20].

Cardiovascular-Kidney-Metabolic Health- From Bench to Bedside[cite: 20, 21].

Cardiovascular-Kidney-Metabolic Health- Therapeutic Innovations[cite: 21].

Celebrating a Century of Cardiovascular Science_ From Prevention to Treatment, to Cure[cite: 21].

Charles T. Dotter Memorial Lecture[cite: 21].

Circulation Cardiovascular Interventions 2023-2024 Editors’ Picks_ The Best and What’s Next[cite: 21, 22].

Circulation_ Innovation in Cardiovascular Science and Medicine[cite: 22].

CKM Health in Asian Populations- What We Know and Don’t Know[cite: 22].

Climate Change-Related Cardiovascular Health Effects in the Global South_ A JAHA_AHA Journals Session[cite: 22, 23].

Clinical Initiatives Driving Meaningful Change for Patients with Advanced Heart Disease[cite: 23].

Clinical Scenarios at the Intersection of Neurocardiac Interventions[cite: 23, 24].

Competing Roles of Lipids in Promotion and Prevention of Atherosclerosis[cite: 24].

Congenital Heart Surgery and ACHD[cite: 24].

Controversies in the Management of Ischemic Heart Disease in Older Patients[cite: 24].

Coronary Artery Anomalies_ Cases, Risk Stratification, and Treatment[cite: 24, 25].

Cournand and Comroe Early Career Investigator Award Competition[cite: 25].

Cross-Talk in Vascular Diseases[cite: 25].

Crossing the Chasm Between Hypertension Guidelines, Clinicians, and Patients_ Time to Act[cite: 25, 26].

Crosstalk Between Lipids and Inflammation in Various Tissues[cite: 26].

Cutting Edge Clinical Cardiomyopathies Research[cite: 26].

Cutting-Edge Genetic and Precision Therapies in Cardiovascular Disease[cite: 26].

Cutting-Edge Insights and New Advances in Cardiac Inflammation[cite: 26, 27].

CVSA Early Career Investigator Abstract Award Competition[cite: 27].

Early Career Day Opening Session[cite: 27].

Editorial Discretion_ Top 3 Papers from Top 3 Cardiovascular Nursing Journals[cite: 27].

EHJ and Circulation_ Advances in 2024[cite: 27, 28].

Elaine W. Raines Early Career Investigator Award Competition[cite: 28].

Elizabeth Barrett-Connor Research Award for Early Career Investigators in Training Competition[cite: 28].

Emerging Therapies for Treatment of Hypertension and Chronic Kidney Disease[cite: 28, 29].

Emerging Topics in Cardiovascular Health Research Among Sexual & Gender Minority Populations[cite: 29].

Environmental Crisis Exposome_ Reshaping the landscape of CV Basic Research and Health Care[cite: 29, 30].

Environmental Impacts on Cardiovascular Health and Biology_ A Circulation Research_AHA Journals Session[cite: 30].

Epidemiology and Population Health[cite: 30].

Epigenomics, RNA Networks, and Cell Plasticity in Pulmonary Hypertension_ New Biomarkers and Therapeutic Targets_[cite: 30, 31].

Equifinality in ACHD Interventions_ Do All Roads Really Lead to Rome_[cite: 31].

Equity in Genomics and Precision Medicine_ Bench to All Bedsides[cite: 31].

Evolving New Technologies in CIED Therapy_ Leadless and Extravascular[cite: 31, 32].

Featured Science_ Amyloid, Hypertrophic, and Danon Cardiomyopathies_ Targeted Therapies and Specific Populations[cite: 32].

Featured Science_ Getting Closer to the Summit_ New HFpEF Treatments[cite: 32, 33].

Featured Science_ Health Technology and the Future of Clinical Trials[cite: 33].

Featured Science_ Incretin Modulation_ Is a New Standard of Care Emerging_[cite: 33].

Featured Science_ Novel Approaches to Managing Lipid Risk[cite: 33, 34].

Featured Science_ Novel Insights in Cardiovascular Interventional Outcomes[cite: 34].

Fixing the Broken Heart_ Mechanisms of Fibrosis[cite: 34].

From Bench to Bedside in Heart Failure[cite: 34].

From Intervention to Prevention_ Advances in Coronary and Valvular Heart Disease[cite: 34, 35].

From Lab to Living Room_ Partnering With the Media to Enhance the Impact of Prevention Science[cite: 35].

From Present to Future, Evolution of Revolutionary Advances in Valvular Heart Disease_ Diagnosis, Management, Science, and Imaging[cite: 35, 36].

Frontiers in Thromboinflammation[cite: 36].

Generative AI in Cardiovascular Health_ A Transformative Force[cite: 36].

Genetics and Outcomes Research[cite: 36].

Genomic and Epidemiology Mid-Career Research Award and Lecture[cite: 36, 37].

Genomic and Precision Medicine Early Career Investigator Award Competition[cite: 37].

George E. Brown Memorial Lecture[cite: 37].

George Lyman Duff Memorial Lecture[cite: 37].

Geriatric Journeys in Cardiology_ Navigating ACS Management Beyond Conventional Guidelines![cite: 37, 38].

Getting All Patients the Vascular Care Warranted-actionable Approaches Towards Dissolving Disparities in Peripheral Vascular Disease[cite: 38].

Getting the Most Out of ChatGPT and Other Large Language Models in Cardiology[cite: 38, 39].

Global Opportunities to Advance Health and Hope_ AHAs 2nd Century Priorities and Global Opportunities in Research[cite: 39].

Global Opportunities to Advance Health and Hope_ Global Implementation of Evidence Based Quality Care[cite: 39, 40].

Global Opportunities to Advance Health and Hope_ Implementation approaches for improved CV Health and Outcomes_ International Approaches[cite: 40, 41].

Global Perspectives on the Future of CVD Care_ System Improvements and Digital Health[cite: 41].

Global Solutions for Prevention of CVD and Stroke[cite: 41].

GLP-1RAs and Beyond_ Incretin Analogues and a New Frontier in Cardiovascular Therapeutics[cite: 41, 42].

Going for Gold_ Championing Community-based Strategies for CVD Health[cite: 42].

Great Debates in Cardio-Oncology_ Let’s Agree to Disagree[cite: 42].

Growing and Re-growing the Cardiovascular System[cite: 42, 43].

Guideline Implementation, Challenges, Success, and Hope[cite: 43].

Health Tech Implementation – From Keyboard to Bedside_ Going From Novel Innovations to Use in Clinical Workflows[cite: 43].

Healthy Moms, Healthy Kids_ Generational Impact on Cardiovascular Disease Across the Lifespan[cite: 43, 44].

Hear Ye Hear Ye! Arresting News in Critical Care Cardiology!![cite: 45, 46].

Heartfelt Innovations_ Interventional Therapeutics for the Management of Acute and Chronic Heart Failure[cite: 46].

Heating Up the Discussion_ Key Debates in Acute Coronary Syndromes[cite: 46].

Helen B. Taussig Memorial Lecture and Abstract Presentations[cite: 46, 47].

Henning Lecture Session_ Non-Traditional Risk Factors & Biomarkers of Peripheral Arterial Disease[cite: 47].

Hot Debates in Heart Failure[cite: 47].

Hot Topics in Valvular Heart Disease[cite: 47, 48].

How Guidelines Diverge_ Navigating Differences between US and European Approaches to Aortic Disease Management[cite: 48].

How Soon is Too Soon_ A New Paradigm for the Preventive Management of Aortic Stenosis[cite: 48, 49].

How to Get the Biggest Bang for Your Buck_ Obtaining Funding and Maximizing Resources During Your Early Career[cite: 49].

How We Use Personalized Genomics in Clinical Cardiology in 2024[cite: 49, 50].

Hypertrophic Cardiomyopathy_ Making Hearts Stronger but Not Pathologic[cite: 50].

Immune Cells at the Heart of Remodeling[cite: 50].

Implementation Science_ On the Cutting Edge of Moving Evidence to Action[cite: 50, 51].

Improving Health Equity in Clinical Algorithms[cite: 51].

Improving Maternal Outcomes A Global Perspective and Discussion on the Mechanisms and Management of Hypertension Among Pregnant[cite: 51].

Innovation in Prevention and Global Implementation[cite: 51, 52].

Innovative Markers and Therapeutic Strategies in Cardiovascular and Neurological Health[cite: 52].

Innovative Progress in Kawasaki Disease Management from East to West[cite: 52].

INOCA Recent Advancement in the Diagnosis and Treatment (AHA Joint Sessions with Japanese Circulation Society)[cite: 52, 53].

Is the Brain at the Heart of the Matter_[cite: 53].

Is the Food is Medicine Initiative Bearing Fruit_ Understanding the Clinical Impact[cite: 53, 54].

Katharine Lembright Award and Lecture and the Martha N. Hill New Investigator Award Competition[cite: 54].

Kenneth D. Bloch Memorial Lecture in Vascular Biology[cite: 54].

Laennec Clinician-Educator Award & Lecture[cite: 54, 55].

Laennec Fellow In Training (FIT) Clinician Award Competition[cite: 55].

Late-Breaking Basic Science_ Exploring New Therapeutic Horizons for Cardiometabolic Disease_ Before Phase 0[cite: 55].

Late-Breaking Basic Science_ Novel Mechanisms in Cardiac Pathophysiology[cite: 55, 56].

Late-Breaking Science_ In-Depth with CLEAR SYNERGY[cite: 56].

Late-Breaking Science_ In-Depth with SUMMIT[cite: 56].

Late-Breaking Science_ In-Depth with VANISH2[cite: 56].

Latest and Greatest in the Medical Management of Heart Failure[cite: 56, 57].

Leading the Charge Preventive Cardiologys Role in Mitigating Cardiovascular Risk (AHA Joint Session with the American Society for Prevent[cite: 57].

Lessons From Community Based Research to Address Disparities in CV Health and Disease[cite: 57, 58].

Leveling the Playing Field_ Creating Equity Within Pediatric Cardiology Leadership and Salary[cite: 58].

Longitudinal Insights and Epidemiological Trends in Cardiovascular and Neurological Health[cite: 58, 59].

Looking to the Future_ Case-based Examples of Novel Ablation Techniques and Technologies at Work[cite: 59].

Louis N. and Arnold M. Katz Basic Science Research Prize for Early Career Investigators Competition[cite: 59, 60].

Lymphatic Function in Neuroinflammation, Metabolic and Cardiac Disease_ Close Relative or Distant Acquaintance_[cite: 60].

MAC Attack_ Deep Dive Into Multidisciplinary Perspectives on Management of Mitral Annular Calcium[cite: 60, 61].

Mastering Mitral Matters_ A Lifetime Journey in Valve Disease Management[cite: 61].

Melvin Judkins Early Career Clinical Investigator Award Competition[cite: 61].

Melvin L. Marcus Early Career Investigator Award in Cardiovascular Sciences Competition[cite: 61, 62].

Microvascular Disease in Children and Adults With Congenital Heart Disease[cite: 62].

Mind Matters_ Elevating Mental Wellness Across Life Stages for Cardiovascular Health[cite: 62].

Mindful Hearts_ Mechanistic Point-of-view[cite: 62, 63].

Mitochondria and Metabolism in Heart Failure[cite: 63].

Mixing it Up_ Pulmonary Hypertension in Patients with Both Heart and Lung Disease[cite: 63].

Molecular Biology Meets Precision Medicine_ Novel Translational Approaches in Cardio-Oncology[cite: 63, 64].

Moving on Up – Transitioning Into Mid-career[cite: 64].

Moving the Needle Towards Scaling Interventions_ Non-pharmacological Intervention Science[cite: 64].

Moving Through the Matrix_ Improving Population Health in the Digital Age[cite: 64, 65].

Multi-Omics for Assessing Disease Susceptibility and Identifying Novel Mechanisms[cite: 65].

Multidisciplinary Approach to Pulmonary Embolism_ Putting Together the Pieces of the Puzzle[cite: 65].

Multifaceted Management of Ventricular Arrhythmias in Advanced Heart Failure[cite: 65, 66].

Multimodality Imaging in Cardio-Oncology ItA’s More Than Just Pretty Pictures[cite: 66].

Nature Cardiovascular Research_ Highlights in Basic, Translational and Clinical Cardiovascular Research[cite: 66].

Navigating the Mix of Meds and Lifestyle for Obesity Medicine[cite: 66, 67].

Navigating the Wilderness_ The Intersection of Immunology and Cardiovascular Disease[cite: 67].

New Discoveries in Microvascular Disease and Coronary Artery Disease_ Sex and Age Differences[cite: 67, 68].

New Insights in Lipids and lipid lowering therapies[cite: 68].

New Insights into Cardiomyopathies that Plague the Cardiologist[cite: 68].

New Pathways and Therapeutic Opportunities in Atherosclerosis[cite: 68].

New Targets and New Treatments_ Advances in Lipid Therapeutics[cite: 68, 69].

Novel and Repurposed Agents for Lowering Risk in ACS[cite: 69].

Novel Immune Mechanisms and Potential Treatments for Hypertension[cite: 69].

Novel Insights Into the Cardiac Contributions to Neurocognition[cite: 69, 70].

Nursing Science and Heart Failure[cite: 70].

Obesity and Cardiovascular Outcomes_ A Lancet Journal Session[cite: 70].

Obesity and HFpEF_ From Mechanisms to Management[cite: 70].

Of Mice and Molecules – Insights into Atrial Arrhythmias and Conduction Disorders[cite: 70, 71].

Optimizing CKM Management in Type 2 Diabetes_ A Practical, Case-based Discussion with Experts[cite: 71].

Optimizing Heart Failure Management Through a Multidisciplinary Approach[cite: 71].

PAD 2024 – Imaging and Intervention with Diversity in Patient Care[cite: 71, 72].

PAD_ Bringing AHA 2024 Guidelines to Cutting Edge Care of the Vascular Patient[cite: 72].

Patterns and Cardiovascular Consequences of Progressive Cardiometabolic Disease[cite: 72, 73].

Paul Dudley White International Lecture and Session[cite: 73].

Pearls to Improve Peri-Procedural Care[cite: 73].

Pecha Kucha Says_ My Achy, Breaky Heart, Infections Can Cause Heart Disease and Heart Failure[cite: 73, 74].

Pecha Kucha_ Future is Now – What is the Best Way to Reduce Blood Pressure Among Patients with Uncontrolled Hypertension[cite: 74].

Pediatric Preventive Cardiology Care to Keep Kids Young at Heart[cite: 74, 75].

Perchance to Dream_ Sleep, Heart, and the Brain[cite: 75].

Perfecting the Poration Process Pulsed-Field Ablation – Whats New[cite: 75].

Personalizing CV Risk_ The Science of CKM Risk Enhancers[cite: 75, 76].

Pivoting With Purpose_ Tips to Change Course and Keep Innovating Your Research[cite: 76].

Pixels to Predictions_ Innovations in Cardiovascular Imaging[cite: 76].

Policy & Social Determinants of Health in Intervention_ Experience in Vascular Disease and Lifestyle Medicine[cite: 76, 77].

Post-Thrombotic Syndrome_ Remastered or Remix_[cite: 77].

Practice-Changing Studies From NEJM_ A Year in Review[cite: 77].

Practicing what we preach solutions for better implementation of secondary CVD prevention. (AHA Joint Session with World Heart Federation)[cite: 78, 79, 80, 81].

Preserving Target Organ Health During Blood Pressure Control_ Challenges and Triumphs[cite: 81].

Primary Prevention of Stroke[cite: 81].

Publishing Without Perishing_ A Discussion With Leading Journal Editors[cite: 81].

Pulmonary Vascular Health and Disease Across the Lifespan[cite: 81, 82].

Pushed Beyond the Brink_ When Chronic Right Ventricular Failure Becomes Acute Right Ventricular Failure[cite: 82].

PVD Lecture and the Jay D. Coffman Early Career Investigator Award Competition[cite: 82, 83].

QCOR Artificial Intelligence for the Outcomes Researcher[cite: 83].

QCOR Early Career Investigator Abstract Award Competition[cite: 83].

QCOR Methods Showdown Pragmatic Trials vs. Implementation Science vs. Community Engaged Research[cite: 83, 84].

QCOR Outcomes Beyond MACE_ A Patient Centered Approach to Management in CV Medicine[cite: 84].

QCOR The Impact of Consolidation, Private Equity, and the Changing Healthcare Market Structure on Cardiovascular Care and Outcomes[cite: 84, 85].

Quest Diagnostics Early Career Investigator Award for Preventive Cardiovascular Medicine Research Competition[cite: 85].

Redefining Arrhythmia Treatment_ Pushing Boundaries[cite: 85].

Research and Innovation Through the Pipeline[cite: 85, 86].

Revolutionizing AF Management_ Cutting-Edge Approaches[cite: 86].

Risky Business_ Understanding and Mitigating Risk in mHealth and Beyond[cite: 86].

Robert I. Levy Memorial Lecture and Lifestyle and Cardiometabolic Health Early Career Investigator Award Competition[cite: 86, 87].

Russell Ross Memorial Lectureship in Vascular Biology[cite: 87].

Samuel A. Levine Early Career Clinical Investigator Award Competition[cite: 87].

Shifting Paradigms in Chronic Coronary Syndromes_ What We Thought We Knew (AHA Joint Session with European Society of Cardiology Society)[cite: 87, 88].

Shocking Developments in Cardiogenic Shock[cite: 88].

Smart Cardiology_ Harnessing AI and Innovation for Better Heart Health[cite: 88].

Smart Hearts_ Transformative Technologies in Cardiovascular Care[cite: 88, 89].

So you want to Build a New Program_[cite: 89].

So, You Want to Do Comparative Clinical Effectiveness Research_[cite: 89].

Social Determinants of Health Screening Across the Research and Care Continuum[cite: 89, 90].

Sol Sherry Distinguished Lecture in Thrombosis[cite: 90].

Stayin’ Alive_ Toward a 100 Year Lifespan in Adult Congenital Heart Disease[cite: 90].

Stroke Council Award and Keynote Lecture[cite: 90, 91].

Sudden Cardiac Death_ Do Genetics Matter_[cite: 91].

Systemic Approach for Heart Failure[cite: 91].

Tackling the Beast_ Changing Behaviors With Patients and Caregivers[cite: 91].

Tackling the Challenge to Improve Outcomes After Sudden Cardiac Arrest Paradigms to Accelerate Detection and Deployment Earlier[cite: 91, 92].

Team Science Approaches for Vascular Disease Research A-AHA SFRN, Sarnoff Foundation, and Leducq Foundation[cite: 92].

Tech-infused Collaboration_ Uniting Science and the Tech Industry to Elevate Cardiovascular Health Through Mental Wellness Solutions[cite: 92, 93].

The Autonomic Nervous System and Cardiovascular Disease_ Is Cardio-neuro Modulation the Next Frontier_[cite: 93].

The Changing Global Landscape of Heart Failure and Cardiomyopathies[cite: 93, 94].

The Current State of the Art in Fontan Care[cite: 94].

The Evolving Landscape of Diabetes and CV Outcomes[cite: 94].

The Future of Lipid Management_ Using Lessons From Our Past[cite: 94, 95].

The Future of Prevention in Cardiometabolic Disease[cite: 95].

The Gangs All Here Cells That Mediate Pulmonary Vascular Disease[cite: 95].

The Latest on a New Cardiovascular Board Whats Happening Now (AHA Joint Session with American College of Cardiology)[cite: 95, 96].

The Long and Winding Road_ From DVT to CTEPH[cite: 96].

The Right Stuff_ Right Heart Failure Beyond the Right Ventricle[cite: 96, 97].

The Risk That is All Around You_ Environmental Exposures and Cardiovascular Disease[cite: 97].

These Legs Are Meant for Walking_ Get to Know the 2024 PAD Guidelines[cite: 97, 98].

Thomas Smith Memorial Lecture[cite: 98].

Timing is Key_ Navigating Early Aortic Valve Replacement Across Ages for Optimal Lifetime Management[cite: 98].

Too Far Gone_ Revascularization of Multivessel CAD in Severe Cardiomyopathy[cite: 98, 99].

Top Takeaways_ 2023 ACC_AHA_ACCP_HRS Guideline for the Diagnosis and Management of Atrial Fibrillation[cite: 99].

Transatlantic Harmony_ Bridging the Divide in Clinical Guidelines Through Case-based Discussions[cite: 99].

Translating ‘Almost’ 100 Years of Lipoprotein Research_ Current and Future Lipoprotein Interventions – Its All in the Mechanism[cite: 99, 100].

Translational Insights into Aortopathies[cite: 100].

Try Everything_ Getting the Best Heart Failure Care to Every Patient_ An AHA Journals session[cite: 100, 101].

Turning the Zone Blue The Role of Primary Care in Achieving LifeA’s Essential[cite: 101].

Unbreak My Heart_ Cardio-Oncology Across the Spectrum of Cardiovascular Disease[cite: 101, 102].

Unequal Hearts_ Tackling Disparities in Cardiovascular Health (AHA Joint Session with the Association of Black Cardiologists)[cite: 102].

Unique Considerations for Managing ASCVD Patients with Chronic Kidney Disease[cite: 102, 103].

Unraveling Cardiovascular Health and Disease in Latinos_ Insights from the SOL Study[cite: 103].

Unraveling the Challenges_ Atrial Fibrillation in Chronic Kidney Disease[cite: 103].

Unveiling the Basic Blueprint_ A Deep Dive into Cardiac Remodeling and Hypertrophic Cardiomyopathy[cite: 103, 104].

Update from the 7th World Symposium on Pulmonary Hypertension[cite: 104].

Using Imaging in Electrophysiological Procedures_ An AHA Journals Session[cite: 104, 105].

Vascular and Valvular Calcification_ An ATVB_AHA Journals Session[cite: 105].

Vascular Disease in Women_ Bridging the Knowledge Gap[cite: 105].

Vascular Disease_ New Frontiers and Mechanisms[cite: 105].

Viva Voce! Veritable Voices on VT ablation[cite: 106, 107].

Vivien Thomas Early Career Investigator Award Competition[cite: 107].

When Right Goes Wrong Molecular Mechanisms Underlying Right Heart Dysfunction in Pulmonary Hypertension[cite: 107].

William W.L. Glenn Lecture[cite: 107, 108].

You Say You Want a Revolution Challenges of Deprescribing to Reduce Polypharmacy in Patients With Cardiovascular Disease[cite: 108].

Young Hearts Early Career Investigator Competition[cite: 108].